Das v Asplin: Prosecution outlines arguments on fraud charges

Southwark Crown Court

Asplin and others have been charged with conspiracy and fraud and are currently standing trial.

The trial of former Das CEO Paul Asplin continued today (18 April) at Southwark Crown Court.

Asplin and the other defendants are standing trial for a number of charges relating to conspiracy and fraud.

The prosecution made arguments alleging how Asplin and his fellow accused hid their involvement in two companies, Med Report and CW Law.

It also detailed that the defendants benefited while those two firms engaged in contracts with Das while Asplin was CEO.

In addition to Asplin the defendants

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Meet the MGA: Ventis

With a ‘breath of fresh air’ Latin-inspired name, CEO Gareth Roberts, pictured second right, explains why Ventis’ USPs of rapid service and sector expertise are helping it gain traction in the real estate market.

Interview: Henry Topham, Allianz

As Allianz rebrands its digital motor insurance product Flow, Insurance Age caught up with managing director of UK retail Henry Topham to hear about his route into insurance and what benefits brokers get from the provider’s omni-channel approach.

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: